All lobbying filings
LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS filed a Q3 report for SAVARA INC. on October 19, 2026, reporting $60,000 in lobbying income.
Lobbying for SAVARA INC. · Biopharmaceutical company focused on rare respiratory diseases.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Pennsylvania
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
4
Lobbying activity
2
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.